Dave Alderman is President of Molekule Consulting (“Molekule”), a global consultancy headquartered in Miami, Florida. Molekule partners with
pharmaceutical, biotechnology and medical device companies providing evidence-based solutions and actionable strategic and tactical insights. Aligning
intelligence outcomes and focusing results thereby enabling our client partners -- blue chip pharmaceutical and biotechnology players -- to win in the highly
dynamic and competitive biopharmaceutical universe, Molekule supports seminal biopharmaceutical business objectives.
We leverage a continuum of tactical and strategic decisions for pharmaceutical, biotechnology and medical device clients via informed, pragmatic and meaningful competitive intelligence & consulting solutions.David is recognized as a Therapy Area Leader (TAL) with an in-depth understanding of multiple disease states, current and future market players, and pipeline compounds in multiple markets and therapeutic areas.
David’s efforts have helped pharmaceutical and biotech companies grow revenues, profits and market share in highly competitive and emerging markets, resulting in a high level of client satisfaction and retention.